JP2004511469A5 - - Google Patents

Download PDF

Info

Publication number
JP2004511469A5
JP2004511469A5 JP2002534293A JP2002534293A JP2004511469A5 JP 2004511469 A5 JP2004511469 A5 JP 2004511469A5 JP 2002534293 A JP2002534293 A JP 2002534293A JP 2002534293 A JP2002534293 A JP 2002534293A JP 2004511469 A5 JP2004511469 A5 JP 2004511469A5
Authority
JP
Japan
Prior art keywords
alkyl
substituted
methyl
substituents
alkoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002534293A
Other languages
English (en)
Japanese (ja)
Other versions
JP4015548B2 (ja
JP2004511469A (ja
Filing date
Publication date
Priority claimed from GBGB0024795.7A external-priority patent/GB0024795D0/en
Application filed filed Critical
Publication of JP2004511469A publication Critical patent/JP2004511469A/ja
Publication of JP2004511469A5 publication Critical patent/JP2004511469A5/ja
Application granted granted Critical
Publication of JP4015548B2 publication Critical patent/JP4015548B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2002534293A 2000-10-10 2001-10-04 ウイルス性疾患の処置のためのピラゾール誘導体 Expired - Fee Related JP4015548B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0024795.7A GB0024795D0 (en) 2000-10-10 2000-10-10 Pyrazole derivatives for the treatment of viral diseases
PCT/EP2001/011474 WO2002030907A1 (en) 2000-10-10 2001-10-04 Pyrazole derivatives for the treatment of viral diseases

Publications (3)

Publication Number Publication Date
JP2004511469A JP2004511469A (ja) 2004-04-15
JP2004511469A5 true JP2004511469A5 (enExample) 2005-04-14
JP4015548B2 JP4015548B2 (ja) 2007-11-28

Family

ID=9900999

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002534293A Expired - Fee Related JP4015548B2 (ja) 2000-10-10 2001-10-04 ウイルス性疾患の処置のためのピラゾール誘導体

Country Status (28)

Country Link
US (2) US6699887B2 (enExample)
EP (1) EP1326843A1 (enExample)
JP (1) JP4015548B2 (enExample)
KR (1) KR100534158B1 (enExample)
CN (2) CN1680333A (enExample)
AR (1) AR030858A1 (enExample)
AU (2) AU2165102A (enExample)
BR (1) BR0114483A (enExample)
CA (1) CA2423515A1 (enExample)
CZ (1) CZ20031297A3 (enExample)
EC (1) ECSP034547A (enExample)
GB (1) GB0024795D0 (enExample)
GT (1) GT200100201A (enExample)
HR (1) HRP20030251A2 (enExample)
HU (1) HUP0302722A2 (enExample)
IL (1) IL154875A0 (enExample)
MA (1) MA26951A1 (enExample)
MX (1) MXPA03003070A (enExample)
NO (1) NO20031615L (enExample)
NZ (1) NZ524740A (enExample)
PA (1) PA8530301A1 (enExample)
PE (1) PE20020750A1 (enExample)
PL (1) PL362918A1 (enExample)
RU (1) RU2270832C2 (enExample)
UY (1) UY26956A1 (enExample)
WO (1) WO2002030907A1 (enExample)
YU (1) YU27203A (enExample)
ZA (1) ZA200302519B (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE310719T1 (de) * 2000-09-29 2005-12-15 Topotarget Uk Ltd Carbaminsäurederivate enthaltend eine amidgruppe als hdac-inhibitoren
GB0113524D0 (en) 2001-06-04 2001-07-25 Hoffmann La Roche Pyrazole derivatives
EP1556381B1 (en) 2002-09-26 2008-02-20 Pfizer Limited Pyrazole amides for treating hiv infections
MXPA05003195A (es) * 2002-09-26 2005-06-08 Pfizer Derivados de pirazol como inhibidores de la transcriptasa inversa.
US7230025B2 (en) 2002-09-26 2007-06-12 Pfizer, Inc. Pyrazole derivatives
GB0223234D0 (en) * 2002-10-07 2002-11-13 Pfizer Ltd Chemical compounds
US6933312B2 (en) 2002-10-07 2005-08-23 Agouron Pharmaceuticals, Inc. Pyrazole derivatives
GB0223232D0 (en) * 2002-10-07 2002-11-13 Pfizer Ltd Chemical compounds
TW200423930A (en) * 2003-02-18 2004-11-16 Hoffmann La Roche Non-nucleoside reverse transcriptase inhibitors
EP1608629A1 (en) 2003-03-24 2005-12-28 F. Hoffmann-La Roche Ag Benzyl-pyridazinons as reverse transcriptase inhibitors
US7220772B2 (en) 2003-09-05 2007-05-22 Pfizer, Inc. Pyrazole derivatives
EP1775298B1 (en) * 2004-07-01 2013-03-20 Daiichi Sankyo Company, Limited Thienopyrazole derivative having pde7 inhibitory activity
US20070005049A1 (en) * 2005-06-30 2007-01-04 Comben Richard H Apparatus and Method of Treating Urinary Incontinence by Heating Urethra
CN101511812A (zh) * 2006-07-05 2009-08-19 辉瑞产品公司 作为细胞色素p450抑制剂的吡唑衍生物
DK2057125T3 (da) 2006-08-16 2011-05-16 Hoffmann La Roche Ikke-nucleosid revers transkriptase-inhibitorer
GB0713479D0 (en) * 2007-07-11 2007-08-22 Syngenta Participations Ag Substituted aromatic heterocyclic compounds as fungicides
RU2495878C2 (ru) 2007-12-21 2013-10-20 Ф.Хоффманн-Ля Рош Аг Гетероциклические антивирусные соединения
GB0823000D0 (en) * 2008-12-17 2009-01-28 Syngenta Participations Ag Isothiazole and pyrazole derivatives with plant growth regulating properties
NZ595233A (en) 2009-02-25 2013-01-25 Daiichi Sankyo Co Ltd Tricyclic pyrazolopyrimidine derivatives
FR2951549B1 (fr) 2009-10-15 2013-08-23 Olivier Schussler Procede d'obtention de bioprotheses medicales implantables
KR20130099006A (ko) 2010-08-23 2013-09-05 다이이찌 산쿄 가부시키가이샤 3 고리성 피라졸로피리미딘 유도체의 프리체 결정
JP5701884B2 (ja) 2010-08-23 2015-04-15 第一三共株式会社 三環性ピラゾロピリミジン誘導体の結晶
WO2014074628A1 (en) * 2012-11-08 2014-05-15 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Compounds for treating hiv and methods for using the compounds
US9925190B2 (en) 2015-02-16 2018-03-27 University of Pittsburgh—of the Commonwealth System of Higher Education Small molecules targeting HIV-1 Nef
JP7301042B2 (ja) 2018-03-30 2023-06-30 住友化学株式会社 複素環化合物及びそれを含有する有害節足動物防除組成物
WO2020081856A1 (en) * 2018-10-18 2020-04-23 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Inhibitors of hiv-1 nef for the treatment of hiv disease
FR3121927B1 (fr) 2021-04-19 2023-03-31 Eiffage Genie Civil Terrassement Procédé d’inertage des boues d’excavation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993015060A1 (fr) 1992-01-22 1993-08-05 Nissan Chemical Industries, Ltd. Derive de pyrazole substitue et bactericide agrohorticole
US6005109A (en) 1997-10-30 1999-12-21 Pflizer Inc. Pyrazoles and pyrazolopyrimidines having CRF antagonistic activity
ATE175961T1 (de) * 1992-12-17 1999-02-15 Pfizer Pyrazole mit crf antagonistischer aktivität
TW336932B (en) * 1992-12-17 1998-07-21 Pfizer Amino-substituted pyrazoles
WO1994013661A1 (en) * 1992-12-17 1994-06-23 Pfizer Inc. Substituted pyrazoles as crf antagonists
WO2006027423A1 (fr) * 2004-08-09 2006-03-16 Simag Developpement Dispositif de saisie comportant un capteur optique suivi d’un moyen de filtrage

Similar Documents

Publication Publication Date Title
JP2004511469A5 (enExample)
RU2003112610A (ru) Производные пиразола для лечения вирксных заболеваний
JP2021119196A5 (enExample)
JP2018535999A5 (enExample)
JP2010505809A5 (enExample)
JP2014526500A5 (enExample)
JP2014526501A5 (enExample)
JP2012528847A5 (enExample)
JP2020521730A5 (enExample)
RU2019118623A (ru) Пирролопиримидины в качестве потенциаторов мвтр
JP2008513514A5 (enExample)
JP2010533158A5 (enExample)
RU99126510A (ru) 3(5)-гетероарилзамещенные пиразолы в качестве ингибиторов киназы p38
JP2009536196A5 (enExample)
JP2010502615A5 (enExample)
JP2012525349A5 (enExample)
JP2014524461A5 (enExample)
RU2008141509A (ru) Mglur5 модуляторы 1
RU2019132212A (ru) Селективные ингибиторы hdac6
JP2006502112A5 (enExample)
RU2010116352A (ru) Производные 1,1,1-трифтор-2-гидрокси-3-фенилпропана
IL263511A (en) 1h-pyrazolo[4,3-b]pyridines as pde1 inhibitors
JP2018534328A5 (enExample)
JP2013531070A5 (enExample)
JP2020520357A5 (enExample)